{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T05:12:46Z","timestamp":1651209166976},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jurology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.juro.2016.12.007","type":"journal-article","created":{"date-parts":[[2016,12,29]],"date-time":"2016-12-29T02:45:58Z","timestamp":1482979558000},"page":"1173-1174","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Re: Sequential bacillus Calmette-Gu\u00e9rin\/Electromotive Drug\u00a0Administration of Mitomycin C as the Standard Intravesical Regimen in High Risk Nonmuscle Invasive Bladder Cancer: 2-Year Outcomes"],"prefix":"10.1097","volume":"197","author":[{"given":"Sunil P.","family":"Shenoy","sequence":"first","affiliation":[{"name":"Division of Urology, Andrology and Renal Transplantation, A. J. Institute of Medical Sciences and Research Centre, Kuntikana, Mangaluru-575003, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashanth K.","family":"Marla","sequence":"additional","affiliation":[{"name":"Division of Urology, Andrology and Renal Transplantation, A. J. Institute of Medical Sciences and Research Centre, Kuntikana, Mangaluru-575003, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pritam","family":"Sharma","sequence":"additional","affiliation":[{"name":"Division of Urology, Andrology and Renal Transplantation, A. J. Institute of Medical Sciences and Research Centre, Kuntikana, Mangaluru-575003, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandu Krishna","family":"Batchu","sequence":"additional","affiliation":[{"name":"Division of Urology, Andrology and Renal Transplantation, A. J. Institute of Medical Sciences and Research Centre, Kuntikana, Mangaluru-575003, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijayanand R.","family":"Reddy","sequence":"additional","affiliation":[{"name":"Division of Urology, Andrology and Renal Transplantation, A. J. Institute of Medical Sciences and Research Centre, Kuntikana, Mangaluru-575003, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek Mangalore","family":"Pai","sequence":"additional","affiliation":[{"name":"Division of Urology, Andrology and Renal Transplantation, A. J. Institute of Medical Sciences and Research Centre, Kuntikana, Mangaluru-575003, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2016.12.007_bib1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1470-2045(05)70472-1","article-title":"Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial","volume":"7","author":"Di Stasi","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.juro.2016.12.007_bib2","first-page":"CD001986","article-title":"Intravesical bacillus Calmette-Guerin in Ta and T1 bladder cancer","volume":"4","author":"Shelley","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.juro.2016.12.007_bib3","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.juro.2007.01.031","article-title":"Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer","volume":"177","author":"Lerner","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2016.12.007_bib4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1464-410X.2011.10880.x","article-title":"Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review","volume":"109","author":"Shelley","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2016.12.007_bib5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.eururo.2011.04.023","article-title":"The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: a systematic review","volume":"60","author":"Lammers","year":"2011","journal-title":"Eur Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534716319279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534716319279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2016.12.007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T04:42:29Z","timestamp":1651207349000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2016.12.007"}},"subtitle":["C. Gan, S. Amery, K. Chatterton, M. S. Khan, K. Thomas and T. O\u2019Brien\n            <i>\n              J Urol 2016;\n              <b>195:<\/b>\n              1697\u20131703.\n            <\/i>"],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["10.1016\/j.juro.2016.12.007"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2016.12.007","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Re: Sequential bacillus Calmette-Gu\u00e9rin\/Electromotive Drug\u00a0Administration of Mitomycin C as the Standard Intravesical Regimen in High Risk Nonmuscle Invasive Bladder Cancer: 2-Year Outcomes","name":"articletitle","label":"Article Title"},{"value":"The Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.juro.2016.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by AMERICAN UROLOGICAL ASSOCIATION EDUCATION AND RESEARCH, INC.","name":"copyright","label":"Copyright"}]}}